Abstract

Background Cytotoxic T lymphocytes (CTLs) are thought to exert immunologic selection pressure of escape mutation. Previous reports have showen that some overlapping peptide epitopes were presented by same HLA molecules. However, the abilities and properties of those CTLs to selection of same escape mutation are not well studied. Methods CTL clones were established by stimulation of PBMC with a synthetic peptide (Nef138-8: RYPLTFGW or Nef138-10: RYPLTFGWCF) by limiting dilution method. Cytotoxic activity toward peptide-loaded cells was performed by 51Cr releasing assay. CTL suppression ability was tested by HIV-1 replication assay toward primary CD4+ cell. In vitro selection of escape mutation was performed by competitive HIV-1 replication assay. The frequency of tetramer positive cells in PBMC of HLA-A*24:02+ patients was detected by flow cytometry analysis. Results Both 8-mer and 10-mer epitopes specific CTLs were established from PBMC of the patients. The ability of Nef138-10-specific CTLs to suppression HIV-1 replication in vitro was much higher than that of Nef138-8-specific CTLs. In addition, at the early stage of infection, Nef13810-specific CTLs was predominantly elicited in the patients more than the latter ones. Cross-reactive Nef1388-specific CTLs recognizing both WT and 2F epitopes were detected in some patients. Moreover, in vitro competitive HIV-1 assay showed that both CTLs can select

Highlights

  • Cytotoxic T lymphocytes (CTLs) are thought to exert immunologic selection pressure of escape mutation

  • In vitro selection of escape mutation was performed by competitive HIV-1 replication assay

  • Both 8-mer and 10-mer epitopes specific CTLs were established from PBMC of the patients

Read more

Summary

Background

Cytotoxic T lymphocytes (CTLs) are thought to exert immunologic selection pressure of escape mutation. The abilities and properties of those CTLs to selection of same escape mutation are not well studied

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.